Latest News and Press Releases

TORONTO, ON--(Marketwired - April 26, 2017) - Beleave Inc. ("Beleave") (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it will begin a clinical research program with Dr. Mohit...

TORONTO, ON--(Marketwired - March 06, 2017) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it is now beginning work on a second drug...

TORONTO, ON--(Marketwired - February 08, 2017) - Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it will begin a collaborative research project with Dr. Lesley Campbell,...

TORONTO, ON--(Marketwired - January 12, 2017) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) is pleased to announce that after receiving its affirmation letter, as announced September 26,...

TORONTO, ON--(Marketwired - December 14, 2016) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) is pleased to announce that it has successfully completed a Natural Sciences and Engineering...

TORONTO, ON--(Marketwired - September 26, 2016) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) is pleased to announce that it has received notification from Health Canada that, upon the...

TORONTO, June 16, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce the addition of retired Lieutenant Colonel Dana Gidlow as the company’s Head of...

TORONTO, June 15, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce that Chris Murphy B.A., M.A., LL.B. will be added to the...

TORONTO, May 03, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce that Andrew Steane will be added to the company’s Advisory Board. With over 20...

TORONTO, ON--(Marketwired - April 18, 2016) - Beleave Inc. (CSE: BE) ("Beleave" or the "Company") is pleased to announce that it has entered into a letter of intent ("LOI") to pursue a...